Cardinal Health (CAH) director granted 1,067 RSUs; owns 4,085
Cardinal Health (CAH) reported a director equity grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cardinal Health (CAH) reported a director equity grant. On 11/05/2025, a board member acquired 1,067 restricted share units at $0, bringing directly held common shares to 4,085 after the transaction.
The grant will vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs before November 5, 2026.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 1,067 | $0.00 | $0.00 |
Footnotes (1)
- F1. Grant of restricted share units that will vest on November 5, 2026, except if the 2026 Annual Meeting of Shareholders is prior to November 5, 2026, then the restricted share units will vest on the date of the 2026 Annual Meeting of Shareholders.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Cardinal Health (CAH) disclose in this Form 4?
What type of securities were involved for CAH?
What relationship does the reporting person have with Cardinal Health (CAH)?
Was there a purchase price for the RSUs?
AI-generated analysis. How Rhea-AI works. Not financial advice.